WAMC New York News
(2004-11-02)
SEATTLE WA
(wgvu) -
RESEARCHERS WILL STUDY AND POSSIBLY IMPROVE THEMILITARY'S MICHIGAN-MADE ANTHRAX VACCINE WITH GRANTS TOTALING 74
(M) MILLION DOLLARS.
ANTHRAX BACTERIA CAN BE USED AS A BIOTERRORISM OR GERM WARFARE
AGENT.
LANSING-BASED BIO-PORT HAS A 245 MILLION-DOLLAR CONTRACT
WITH THE PENTAGON TO SUPPLY THE MILITARY WITH ANTHRAX VACCINE.
MANDATORY ANTHRAX VACCINATIONS FOR SERVICE PERSONNEL WERE HALTED
LAST WEEK. A LAWSUIT AGAINST THE PENTAGON ARGUED THAT THE VACCINE
WAS RUSHED THROUGH APPROVAL BEFORE THE IRAQ WAR, AND THERE'S
EVIDENCE IT HAS CAUSED IMMUNE ILLNESSES AMONG SOLDIERS.
THE GRANTS ANNOUNCED YESTERDAY ARE AIMED AT DEVELOPING BETTER
VACCINES OR MEDICATIONS FOR USE AGAINST INFECTIOUS AGENTS.
(COPYRIGHT 2004 BY THE ASSOCIATED PRESS. ALL RIGHTS RESERVED.)
© Copyright 2012, wgvu
Facebook
Twitter
YouTube
Flickr